Patient info

MST Continus 200 mg prolonged-release tablets – Summary of Product Characteristics (SmPC) for healthcare professionals

Medicine status: Controlled drug (Schedule 2) No longer supplied Details

Medicine strength:
200 mg
Other strengths and forms:
Contains active substance:
ATC code:
Similar medicines:

Summary of Product Characteristics (SmPC) - MST Continus 200 mg prolonged-release tablets

Sources: Original (products.mhra.gov.uk)

Facts about MST Continus 200 mg prolonged-release tablets

Controlled drug
Yes, Schedule 2 of the Misuse of Drugs Regulations?
  • Controlled drugs are medicines that UK law controls more strictly because they can be misused or cause dependence. The Misuse of Drugs Regulations 2001 divide them into 5 schedules: schedule 1 has the strictest rules, schedule 5 the lightest.
  • Schedule 2 is the strictest group of prescribed medicines, for example strong opioid painkillers and medicines for ADHD.
  • A prescription is valid for 28 days and usually covers up to 30 days of treatment. It cannot be issued as a repeat dispensing prescription.
  • When you collect it, the pharmacist must check whether you are the patient and may ask for ID.
  • Travelling abroad: you can usually carry up to 3 months' supply. Take your prescription or a letter from your doctor to show it is yours, and check the rules of the country you are going to (GOV.UK).
  • Never give it to anyone else.
Active substance Morphine
Strength 200 mg
Pharmaceutical form Modified-release tablet
How is it taken Oral
Is it available? No, all its packs are listed as discontinued (NHS Dictionary of Medicines and Devices – not a record of current supplies)
Drug group (ATC)
  1. N Nervous system drugs
    1. N02 Analgesics
      1. N02A Opioid analgesics
        1. N02AA Natural opium alkaloid analgesics
          1. N02AA01 morphine
Codes BNF 04070200

Sources: the NHS Dictionary of Medicines and Devices (dm+d), release 10.2.0 of 19 October 2026, NHS Business Services Authority. Contains public sector information licensed under the Open Government Licence v3.0.